COMMONWEALTH OF AUSTRALIA
Instrument number PB 83 of 2013
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment December 2013 - specification under subsection 84AAA(2)1
 
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
 
I, Felicity McNeill, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
 
Dated  27  November 2013
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
Amendment determination — Pharmaceutical Benefits - Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment December 2013 - specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as No. PB 83 of 2013.
 
2          Commencement
 
This Instrument commences on 1 December 2013.
 
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
 
Schedule 1        Amendments
 
[1]                       Schedule 1, after item dealing with Atorvastatin
insert in the columns in the order indicated:
 
Atorvastatin with ezetimibe
Pack containing 30 tablets atorvastatin 10 mg (as calcium) and 30 tablets ezetimibe 10 mg
Oral
1
5
 

Pack containing 30 tablets atorvastatin 20 mg (as calcium) and 30 tablets ezetimibe 10 mg
Oral
1
5
 

Pack containing 30 tablets atorvastatin 40 mg (as calcium) and 30 tablets ezetimibe 10 mg
Oral
1
5
 

Pack containing 30 tablets atorvastatin 80 mg (as calcium) and 30 tablets ezetimibe 10 mg
Oral
1
5
 

 
 
 
 
[2]                       Schedule 1, after item dealing with Isosorbide mononitrate
insert in the columns in the order indicated:
 
Ivabradine
Tablet 5 mg
Oral
56
5
 

Tablet 7.5 mg
Oral
56
5
 

 
 
 
 
 
 
[3]                        Schedule 1, after item dealing with Olmesartan with amlodipine
insert in the columns in the order indicated:
 
Olmesartan with amlodipine and hydrochlorothiazide
Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besylate) and hydrochlorothiazide 12.5 mg
Oral
30
5
 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besylate) and hydrochlorothiazide 12.5 mg
Oral
30
5
 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besylate) and hydrochlorothiazide 25 mg
Oral
30
5
 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besylate ) and hydrochlorothiazide 12.5 mg
Oral
30
5
 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besylate) and hydrochlorothiazide 25 mg
Oral
30
5
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.comlaw.gov.au.